Skip to content

Clinical trials

Hemorrhagic Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20172
20182
20191
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Enrolling by invitation1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical2
Genzyme, a Sanofi Company2
CTI BioPharma1
Hutchmed1
Kedrion S.p.A.1
Ludwig-Maximilians - University of Munich1
Novartis Pharmaceuticals1
Sierra Oncology LLC - a GSK company1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Disorders11
Hematologic Diseases10
Blood Coagulation Disorders9
Coagulation Protein Disorders5
Genetic Diseases, Inborn5
Hemophilia A5
Blood Coagulation Disorders, Inherited4
Blood Platelet Disorders3
Bone Marrow Diseases3
Hemophilia B3

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.